The Multixenobiotic Resistance Mechanism in Aquatic Organisms

References

• Sieben B., Bihari N., Kurelec B., Zahn R. K. Polycyclic aromatic hydrocarbon levels in waters and sponges of the Northern Adriatic. Thailasia Jugosl. 1986; 21: 113
   Google Scholar
• Malins D. C., Hodgins H. O., Varanasi U., Macleod W. D., McCain B. B., Chan S. L. Chemical measurements of organic pollutants and effects criteria, in. Concepts in Marine Pollution Measurements, H. V. White. A Maryland Sea Grant Publication, University of Maryland, College Park 1984; 405
   Google Scholar
• Juliano R. L., Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 1976; 455: 152
   PubMed Web of Science ®Google Scholar
• Morrow C. S., Cowan K. H. Mechanisms and clinical significance of multidrug resistance. Oncology 1988; 2: 55
   PubMedGoogle Scholar
• Kureiec B., Pivcevic B. Distinct glutathione-dependent enzyme activities and a verapamil sensitive binding of xenobiotics in a fresh-water mussel. An-odonta cygnea, Biochem. Biophys. Res. Commun. 1989; 164: 934
   PubMedGoogle Scholar
• Kurelec B., Pivcevk B. Evidence for a mul-tixenobiotic resistance mechanism in the mussel. My-tilusgalloprovincialis, Aquat. Toxicol. 1991; 19: 291
   Google Scholar
• Kurelec B., Pivcevic B. The multidrug resistance-like mechanism in a marine sponge. Tethya au-rantium, Mar. Environ. Res., in press
   Google Scholar
• Kurelec B., Krca S., Pivcevic B., Ugarkovic D., Bachmann M., Imsiecke G., Muller W. E.G. Expression of P-glycoprotein gene in marine sponges. Identification and characterization of the 125-kDa drug-binding glycoprotein. Carcinogenesis 1992; 13: 69
   PubMedGoogle Scholar
• Biedler J. L., Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. 1970; 30: 1174
   PubMed Web of Science ®Google Scholar
• Bech-Hansen N. T., Till J. E., Ling V. Pleiotropic phenotype of colchicine-resistant CHO cells cross-resistance and collateral sensitivity. J. Cell Physiol. 1976; 88: 23
   PubMed Web of Science ®Google Scholar
• Ling V., Thompson L. H. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J. Cell Physiol. 1974; 83: 103
   PubMed Web of Science ®Google Scholar
• Kartner N., Riordan J. R., Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 1983; 221: 1285
   PubMed Web of Science ®Google Scholar
• Inaba M., Fujikura R., Sakuri Y. Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia. Biochem. Pharmacol. 1981; 30: 1863
   PubMed Web of Science ®Google Scholar
• Cornwell M. M., Safa A. R., Felsted R. L., Gottesman M. M., Pastan I. H. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 3847
   PubMed Web of Science ®Google Scholar
• Cornwell M. M., Gottesman M. M., Pastan I. H. Increased vinblastine binding to membrane vesicles from multi-drug resistant KB cells. J. Biol. Chem. 1986; 261: 7921
   PubMed Web of Science ®Google Scholar
• Safa A. R., Glover C. J., Meyers M. B., Biedler J. L., Felsted R. L. Vinblastine photoaffinity labeling of high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. J. Biol. Chem. 1986; 261: 6137
   PubMed Web of Science ®Google Scholar
• Safa A. R., Glover C. J., Sewell J. L., Meyers M. B., Biedler J. L., Felsted R. L. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J. Biol. Chem. 1987; 262: 7884
   PubMed Web of Science ®Google Scholar
• Endicott J. A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 1989; 58: 137
   PubMed Web of Science ®Google Scholar
• Kane S. E., Pastan I., Gottesman M. M. Genetic basis of multidrug resistance of tumor cells. J. Bioeng. Biomembr. 1990; 22: 593
   PubMed Web of Science ®Google Scholar
• Riordan J. R., Deuchars K., Kartner M., Alon N., Trent J., Ling V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 1985; 316: 817
   PubMed Web of Science ®Google Scholar
• Ueda K., Cornwell M. M., Pastan I., Roninson I. B., Ling V., Riordan J. R. The mdr 1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem. Biophys. Res. Commun. 1986; 141: 956
   PubMed Web of Science ®Google Scholar
• Chen C.-J., Chin J. E., Ueda K., Clark D. P., Pastane I., Gottesman M. M., Roninson I. B. Internal duplication and homology with bacterial transport proteins in the mdrl (p-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381
   PubMed Web of Science ®Google Scholar
• Gros P., Croop J., Housman D. E. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 1986; 47: 371
   PubMed Web of Science ®Google Scholar
• Shen D. V.V., Fojo A., Chin J. E., Roninson I. B., Richert N., Pastan I., Gottesman M. M. Human multidrug-resistant cell lines: increased mdrl expression can precede gene amplification. Science 1986; 232: 643
   PubMed Web of Science ®Google Scholar
• Shen D., Fojo A., Roninson I. B., Chin J. E., Soffin R., Pastan I., Gottesman M. M. Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdrl gene. Mol. Cell Biol. 1986; 6: 4039
   PubMed Web of Science ®Google Scholar
• Gros P., Neriah Y. B., Croop J. M., Housman D. E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 1986; 323: 728
   PubMed Web of Science ®Google Scholar
• Ueda K., CardeUi C., Gottesman M. M., Pastan I. Expression of a full-length cDNA for the human “MDR1” gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 3004
   PubMed Web of Science ®Google Scholar
• Guild B. C., Mulligan R. C., Gros P., Housman D. E. Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 1595
   PubMed Web of Science ®Google Scholar
• Hamada H., Tsuruo T. Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 1988; 48: 4926
   PubMed Web of Science ®Google Scholar
• Silver S., Nucifora G., Chu L., Misra T. K. Bacterial resistance ATPases: primary pumps for exporting toxic cations and anions. TIBS 1989; 14: 76
   PubMed Web of Science ®Google Scholar
• Bradley G., Juranka P. F., Ling V. Mechanism of multidrug resistance. Biochim. Biophys. Acta 1988; 948: 87
   PubMed Web of Science ®Google Scholar
• Ueda K., Cornwell M. M., Gottesman M., Pastan I., Roninson I., Ling V., Riordan J. R. The mdrl gene, responsible for multidrug-resistance, codes for the p-glycoprotein. Biochem. Biophys. Res. Commun. 1986; 141: 956
   PubMed Web of Science ®Google Scholar
• Sugimoto Y., Roninson I. B., Tsuruo T. Decreased expression of the amplified mdrl gene in revertants of multidrug-resistant human myelogenous leukemia K5662 occurs without loss of amplified DNA. Mol. Cell Biol 1987; 7: 4549
   PubMed Web of Science ®Google Scholar
• Bellamy W. T., Dalton W. S., Dorr R. T. The clinical relevance of multidrug resistance. Cancer Invest. 1990; 8: 545
   Google Scholar
• Marino P. A., Gottesman M. M., Pastan I. Regulation of the multidrug resistance gene in regenerating rat liver. Cell Growth Differ. 1990; 1: 57
   PubMedGoogle Scholar
• Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham M. C. Cellular localisation of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 7735
   PubMed Web of Science ®Google Scholar
• Sugawara I., Kataoka I., Morishita Y., Hamada H., Tsuruo T., Itoyama S., Mori S. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody MRK 16. Cancer Res. 1926; 48: 1988
   Google Scholar
• Arceci R. J., Croop J. M., Horwitz S. B., Housman D. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 4350
   PubMed Web of Science ®Google Scholar
• Arceci R. J., Baas F., Raponi R., Horwitz S. B., Housman D., Croop J. M. Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Mol. Reprod. Dev. 1990; 25: 101
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R., Bertino J. R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 695
   PubMed Web of Science ®Google Scholar
• Qian X., Beck W. T. Progesterone photoaffinity labels P-glycoprotein in multidrug-resistant human leukemic lymphoblasts. J. Biol. Chem. 1990; 265: 18753
   PubMed Web of Science ®Google Scholar
• Tsuruo T., Iida H., Tsukagoshi S., Sukurai Y. Overcoming of vincristine resistance in P388 leukemia,in vivoin vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1967; 41: 1981
   Google Scholar
• Fojo A., Akiyama S. I., Gottesman M. M., Pastan I. Reduced drug accumulation in multiplay drug-resistant human KB carcinoma cell lines. Cancer Res. 1985; 45: 3002
   PubMed Web of Science ®Google Scholar
• Beck W. T. Strategies to circumvent multidrug resistance due to P-glycoprotein or to altered DNA topisomerase II. Bull. Cancer 1131; 77: 1990
   Google Scholar
• Krogstad D. J., Gluzman I. Y., Kyle D. E., Oduola A. M.J., Martin S. K., Milhous V. K., Schlesinger P. H. Efflux of chloroquine fromPlasmodium falciparum mechanism of chloroquine resistance. Science 1987; 238: 1285
   PubMedGoogle Scholar
• Wellems T. E., Panton L. J., Gluzman I. Y., do Rosario V. E., Gwadz R. W., Walker-Jonah A., Krogstad D. J. Chloroquine resistance not linked to mdr-like genes in aPlasmodium falciparum cross. Nature 1990; 345: 253
   PubMed Web of Science ®Google Scholar
• Foote S. J., Kyle D. E., Martin R. K., Oduola A. M.J., Forsyth K., Kemp D. J., Cowman A. F. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in. Plasmodium falciparum, Nature 1990; 345: 255
   PubMed Web of Science ®Google Scholar
• Ayala P., Samuelson J., Wirth D., Orozco E. Entamoeba histolytica: physiology of multidrug resistance. Exp. Parasitol. 1990; 71: 169
   PubMedGoogle Scholar
• Samuelson J., Ayala P., Orozco E., Wirth D. Emetine-resistant mutant ofEntamoeba histolytica overexpress mRNAs for multidrug resistance. Mol. Biochem. Parasitol. 1990; 38: 281
   PubMedGoogle Scholar
• Safa A. R. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil. Proc. Natl. Acad. Sci. U.S.A. 7187; 85: 1988
   Google Scholar
• Yusa K., Tsuruo T. Reversal mechanism of multidrug resistance by verapamil to P-glycoprotein on specific sites and transport of verapamil outwards across the plasma membrane of K562/ADM cells. Cancer Res. 1989; 49: 5002
   PubMed Web of Science ®Google Scholar
• West I. C. What determines the substrate specificity of the multidrug-resistance pump?. TIBS 1990; 5: 42
   Google Scholar
• Hofsli E., Nissen-Meyer J. Reversal of multidrug resistance by lipophilic drugs. Cancer Res. 1990; 50: 3997
   PubMed Web of Science ®Google Scholar
• Neyfakh A. Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell Res. 1988; 174: 168
   PubMed Web of Science ®Google Scholar
• Bucana C. D., Giavazzi R., Nayar R., O'Brien C. A., Seid C., Earnest L. E., Fan D. Retention of vital dyes correlated inversely with the multidrug-resistant phenotype of adriamycin-selected murine fibrosarcoma variants. Exp. Cell Res. 1990; 190: 69
   PubMed Web of Science ®Google Scholar
• Ichikawa M., Yoshhnura A., Sumizawa T., Shudo N., Kuwazaru Y., Furukawa T., Akiyama S. Interaction of organic chemicals with P-glycoprotein in the adrenal gland, kidney, and a multidrug-resistant KB cell. J. Biol. Chem. 1991; 266: 903
   PubMed Web of Science ®Google Scholar
• Efferth T., Loehrke H., Volm M. Reciprocal expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res. 1989; 9: 1633
   PubMed Web of Science ®Google Scholar
• Yoshimura A., Shudo N., Ikeda S., Ichikawa M., Sumizawa T., Akiyama S. I. Novel screening method for agents that overcome classical multidrug resistance in a human cell line. Cancer Lett. 1990; 50: 45
   PubMed Web of Science ®Google Scholar
• Cowan K. H., Batist G., Tulpule A., Sinha B. K., Myers C. E. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 9328
   PubMed Web of Science ®Google Scholar
• Fairchild C. R., Ivy S. P., Rushmore T., Lee G., Koo P., Goldsmith M. E., Myers C. E., Farber E., Cowan K. H. Carcinogen-induced mdr overexpression is associated with xeno-biotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 7701
   PubMed Web of Science ®Google Scholar
• Center M. S. Mechanisms regulating cell resistance to adriamycin: evidence that drug accumulation in resistant cells is modulated by phosphorylation of a plasma membrane glycoprotein. Biochem. Pharmacol. 1471; 34: 1985
   Google Scholar
• Chambers T. C., Chalikonda I., Eilon G. Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem. Biophys. Res. Commun. 1990; 169: 253
   PubMedGoogle Scholar
• Ma L., Marquardt D., Takemoto L., Center M. S. Analysis of P-glycoprotein phos-phorilation in HL60 cells isolated for resistance to vincristine. J. Biol. Chem. 1991; 266: 5593
   PubMedGoogle Scholar
• Miyamoto K. I., Wakusawa S., Nakamura S., Koshiura R., Otsuka K., Naito K., Hagiwara M., Hidaka H. Circumvention of multidrug resistance in P388 murine leukemia cells by a novel inhibitor of cyclic AMP-dependent protein kinase, H-87. Cancer Lett. 1990; 51: 37
   PubMedGoogle Scholar
• Batist G., Tulpule A., Sinha B. K., Katki A. G., Meyers C. E., Cowan K. H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cells. J. Biol. Chem. 1986; 261: 15544
   PubMed Web of Science ®Google Scholar
• Kramer R. A., Zakher J., Kim G. Role of the glutathione redox cycle in acquired andde novo multidrug resistance. Science 1988; 241: 694
   PubMed Web of Science ®Google Scholar
• Pickett C. D., Lu A. Y.H. Glutathione S-transferase: gene structure, regulation, and biological function. Annu. Rev. Biochem. 1989; 58: 743
   PubMed Web of Science ®Google Scholar
• Moscow J. A., Fairchild C. R., Madden M. J., Ransom D. T., Wieand H. S., O'Brien E. E., Poplack D. G., Cossman J., Myers C. E., Cowan K. H. Expression of anionic glutathiones-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989; 49: 1422
   PubMed Web of Science ®Google Scholar
• Burt R. K., Garfield S., Johnson K., Thorgeirsson S. S. Transformation of rat liver epithelial cells withv-W-ras orv-ras causes expression of MDR-1, glutathione S-transferase-P and increased resistance to cytotoxic chemicals. Carcinogenesis 1988; 9: 2329
   PubMed Web of Science ®Google Scholar
• Yusa K., Hamada H., Tsuruo T. Comparison of glutathione S-transferase activity between drug-resistant and -sensitive human tumor cells: is glutathione S-transferase associated with multidrug resistance?. Cancer Chemother. Pharmacol. 1988; 22: 17
   PubMed Web of Science ®Google Scholar
• Fairchild C. R., Moscow J. A., O'Brien E. E., Cowan K. H. Multidrug-resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-P. Mol. Pharmacol 1990; 37: 801
   PubMed Web of Science ®Google Scholar
• Naito M., Hamada H., Tsuruo T. ATP/ Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells. J. Biol. Chem. 1988; 263: 11887
   PubMed Web of Science ®Google Scholar
• Richert N. D., Aldwin L., Nitecki D., Gottesman M. M., tan I. Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells. Biochemistry 1988; 27: 7607
   PubMed Web of Science ®Google Scholar
• Epstein J., Xiao H. Q., Oba B. K. P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD. Blood 1989; 74: 913
   PubMed Web of Science ®Google Scholar
• Fojo A. T., Ueda K., Slamon D. J., Poplack D. G., Gottesman M. M., Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 265
   PubMed Web of Science ®Google Scholar
• Gupta R. C. Enhanced sensitivity of32P-postla-beling analysis of aromatic carcinogen DNA adducts. Cancer Res. 5656; 45: 1985
   Google Scholar
• Beland F. A., Huitfeld, Poirier M. C. DNA adduct formation and removal during chronic administration of a carcinogenic aromatic amine. Prog. Exp. Tumor Res. 1987; 31: 33
   PubMedGoogle Scholar
• Kurelec B., Garg A., Krca S., Gupta R. C. DNA adducts as biomarkers in genotoxic risk assessment in the aquatic environment. Mar. Environ. Res. 1989; 28: 317
   Web of Science ®Google Scholar
• Bellamy W. T., Dalton W. S., Kailey J. M., Gleason M. C., McCloskey T. M., Dorr R. T., Alberts D. S. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage. Cancer Res. 1988; 48: 6365
   PubMed Web of Science ®Google Scholar
• Kurelec B., Garg A., Krca S., Britvic S., Lucie D., Gupta R. C. DNA adducts in carp exposed to artificial crude- and Diesel 2-oil slicks. Eur. J. Pharmacol. 1992; 228: 51
   PubMedGoogle Scholar
• Liehr J. G., Avitts T. A., Randerath E., Randerath K. Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 5301
   PubMed Web of Science ®Google Scholar
• Gottesman M. M., Pastan I. Clinical trials of agents that reverse multidrug-resistance. J. Clin. Oncol. 1989; 7: 409
   PubMed Web of Science ®Google Scholar
• Choi K., Chen C., Kriegler M., Roninson I. B. An altered pattern of cross-resistance in multidrug resistant human cells results from spontaneous mutations in the mdrl (P-glycoprotein) gene. Cell 1988; 53: 519
   PubMed Web of Science ®Google Scholar
• Graham-Bryce I. J. Resistance to pesticides and antibiotics: how far is it comprehensible and manageable?, in. Combating Resistance to Xenobiotics: Biological and Chemical Approaches, M. G. Ford, D. W. Holloman, B. P.S. Khanbay, R. M Sawicki. Ellis Horwood, ChichesterUK 1987; 11, s
   Google Scholar
• Sawicki R. M. Definition, detection and documentation of insecticide resistance, in. Combating Resistance to Xenobiotics: Biological and Chemical Approaches, M. G. Ford, D. W. Holloman, B. P.S. Khanbay, R. M. Sawicki. Ellis Horwood, ChichesterUK 1987; 105
   Google Scholar
• Kurelec B., Garg A., Krca S., Gupta R. C. DNA adducts in marine mussel Mytilus galloprovincialis living in polluted and unpolluted environments, in. Biomarkers of Environmental Contamination, J. F. McCarthy, R. L. Schugart. Lewis Publishers, Boca Raton, FL 1990; 217, s
   Google Scholar
• Sklar M. D. Increased resistance to cis-diammi-nedichloroplatinum(II) in NIH 3T3 cells transformed byras oncogenes. Cancer Res. 1988; 48: 793
   PubMed Web of Science ®Google Scholar
• Sklar M. D. Theras oncogenes increase intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 1988; 239: 645
   PubMed Web of Science ®Google Scholar
• Niimi S., Nakagawa K., Yokota J., Tsunokawa Y., Nishio K., Terashima Y., Shibuya M., Terada M., Saio N. Resistance to anticancer drugs in NIH3T3 cells transfected withc-myc and/orc-H-ras genes. Br. J. Cancer 1991; 63: 237
   PubMed Web of Science ®Google Scholar
• Yamashita K., Adachi M., Kato S., Nakagama H., Ochiai M., Wakabayashi K., Sato S., Nagao M., Sugimura T. DNA adducts formed by 2-amino-3,8-dimethilimidazo(4,5-f) quinoxaline in rat liver: dose-response on chronic administration. Jpn. J. Cancer Res. 1990; 81: 470
   PubMedGoogle Scholar
• Ugarkovic D., Kurelec B., Krca S., Batel R., Robitzki Muller W. E.G., Schroder H. C. Alterations in raj-gene expression and intracellular distribution of protein kinase C in the spongeGeodia cydonium in response to marine pollution. Mar. Biol. 1990; 107: 191
   Google Scholar
• Kurelec B. The genotoxic disease syndrome. Mar. Environ. Res., in press
   Google Scholar
• Jakoby W. B., Ziegler D. M. The enzymes of detoxification. J. Biol. Chem. 1990; 265: 20715
   PubMed Web of Science ®Google Scholar
• Parodi S., Taningher M., Santi L., Cavanna M., Sciaba L., Mawra A., Brambilla G. A practical procedure for testing DNA damage in vivo proposed for a pre-screening of chemical carcinogens. Mutat. Res. 1978; 54: 39
   PubMed Web of Science ®Google Scholar
• Horio M., Gottesman M. M., Pastan I. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 3580
   PubMed Web of Science ®Google Scholar
• Holland-Toomey B. Hopkins Marine Station. Stanford University, Pacific Grove, CA, personal communication
   Google Scholar
• Kurelec B., Garg A., Pivcevic B., DeFlora S., Gupta R. C., unpublished results
   Google Scholar
• Kurelec B., Waldmann E., Garg A., Zahn R. K., Gupta R. C., in preparation
   Google Scholar